Get started
Author

Daiki Ikarashi

High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs
2022 · Hiroko Onagi, Yoshiya Horimoto, et al. · Breast Cancer Research · 47
PDF
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
2020 · Daichi Tamura, Noriaki Jinnouchi, et al. · International Journal of Clinical Oncology · 47
Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy
2021 · Asumi Sakaguchi, Yoshiya Horimoto, et al. · Breast Cancer Research · 37
PDF
Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma
2023 · Daichi Tamura, Masakazu Abe, et al. · Cancer Science · 34
PDF
Appropriate preoperative membranous urethral length predicts recovery of urinary continence after robot-assisted laparoscopic prostatectomy
2018 · Daiki Ikarashi, Yoichiro Kato, et al. · World Journal of Surgical Oncology · 32
PDF
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
2021 · Daiki Ikarashi, Tamio Okimoto, et al. · JTO Clinical and Research Reports · 30
PDF
Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma
2018 · Daiki Ikarashi, Yoichiro Kato, et al. · International Journal of Urology · 29
PDF
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
2021 · Daiki Ikarashi, Shigehisa Kitano, et al. · British Journal of Cancer · 28
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
2020 · Renpei Kato, Noriaki Jinnouchi, et al. · Translational Oncology · 26
PDF
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
2022 · Takayuki Ueno, Shigehisa Kitano, et al. · BMC Medicine · 21
Association between response to enfortumab vedotin and peripheral neuropathy in urothelial carcinoma patients: a multicenter retrospective study
2024 · Nozomi Hayakawa, Eiji Kikuchi, et al. · Japanese Journal of Clinical Oncology · 20
PDF
Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients
2019 · Mitsugu Kanehira, Ryo Takata, et al. · International Journal of Clinical Oncology · 17
Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations
2020 · Takuo Hayashi, Shinji Kohsaka, et al. · Histopathology · 14
Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma
2025 · Shingo Hatakeyama, Naoki Fujita, et al. · Scientific Reports · 10
PDF
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report
2020 · Daiki Ikarashi, Shigehisa Kitano, et al. · Frontiers in Oncology · 10
PDF
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
2024 · Daiki Ikarashi, Shigehisa Kitano, et al. · Scientific Reports · 9
PDF
Efficacy of Everolimus for Treating Renal Angiomyolipoma with Inferior Vena Cava Thrombus Associated with Tuberous Sclerosis: A Case Report
2017 · Daiki Ikarashi, Yoshiharu Mue, et al. · Urology Case Reports · 9
PDF
Durable Response After Combination Therapy With Enfortumab Vedotin and Radiotherapy in Metastatic Urothelial Carcinoma: A Report of Two Cases
2023 · Daiki Ikarashi, Koyo Kikuchi, et al. · Cureus · 8
PDF
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1
2023 · Yoshinori Kikuchi, Hideaki Shimada, et al. · International Journal of Clinical Oncology · 8
Complete response to perioperative treatment using nivolumab for metastatic renal cell carcinoma: A case report
2019 · Daiki Ikarashi, Yasuyuki Nakamura, et al. · Urology Case Reports · 8
PDF
Pelvic Artery Calcification Score Is a Marker of Vascular Calcification in Male Hemodialysis Patients
2018 · Tomohiko Matsuura, Takaya Abe, et al. · Therapeutic Apheresis and Dialysis · 8
Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer
2024 · Yoshiaki Nagatani, Naomi Kiyota, et al. · Asia-Pacific Journal of Clinical Oncology · 7
PDF
Pathological Complete Response to Preoperative Nivolumab Plus Cabozantinib for Renal Cell Carcinoma With Inferior Vena Cava Thrombus: A Case Report
2022 · ARISA MACHIDA, DAIKI IKARASHI, et al. · Cancer Diagnosis & Prognosis · 7
PDF
Analyses of Nivolumab Exposure and Clinical Safety Between 3-mg/kg Dosing and 240-mg Flat Dosing in Asian Patients with Advanced Renal Cell Carcinoma in the Real-World Clinical Setting
2020 · Renpei Kato, Daiki Ikarashi, et al. · Translational Oncology · 7
PDF
Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study
2025 · Daiki Ikarashi, Nozomi Hayakawa, et al. · International Journal of Clinical Oncology · 6
PDF
Works count: 128
Citation count: 570
H-index: 13
I10-index: 15
Year
Topic
Type